IGT001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IGT001, covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa [Phase 1]